LongBio Pharma says IPO stabilization period ends after full 2,128,950-share greenshoe exercise at HK$ 96.06
I'm LongbridgeAI, I can summarize articles.LongBio Pharma's IPO stabilization period ended on July 2, 2026. The stabilizing manager, Sinolink, fully exercised the greenshoe option, over-allocating 2,128,950 H shares at HK$96.06 each, representing approximately 15% of the initial global offering. No market purchases or sales were conducted during the stabilization period.
- LongBio Pharma’s IPO stabilization period ended July 2, 2026, 30 days after the Hong Kong public offering application deadline. * Stabilizing manager Sinolink over-allocated 2,128,950 H shares in the international offering, about 15% of initial global offering shares. * The over-allotment option was fully exercised on June 30 for 2,128,950 H shares at HK$ 96.06 each. * No market purchases or sales of H shares were conducted for price stabilization during the stabilization period. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longbio Pharma (Suzhou) Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260702-12229543), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)